+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anti Thrombotics Global Market Report 2020

  • ID: 4852473
  • Report
  • November 2019
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Bristol Myers Squibb
  • Eli Lilly
  • Johnson & Johnson
  • Sanofi
  • MORE
Anti Thrombotics Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global anti thrombotics market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the anti thrombotics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti Thrombotics Market Global Report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market
  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
  • Markets Covered: 1) By Application: Blood Clot Prevention, Hyperlipidemia Treatment, Prophylactic Treatment, Thromboembolic Disease Treatment, Other Applications 2) By Type: Anticoagulant, Antiplatelet, Thrombolytic Drugs 3) By Class: Fondaparinux, Heparin, Apixaban, Debigatran, Rivaroxaban 4) By Route Of Administration: Oral, Parenteral Route 5) By Distribution Channel: Hospital Pharmacies, Online Retailers, General Pharmacies, Drug Stores
  • Companies Mentioned: Bayer AG, Johnson & Johnson, Sanofi, Boehringer Ingelheim Gmbh, Eli Lilly
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Bristol Myers Squibb
  • Eli Lilly
  • Johnson & Johnson
  • Sanofi
  • MORE
1. Executive Summary

2. Anti Thrombotics Market Characteristics

3. Anti Thrombotics Market Size And Growth
3.1. Global Anti Thrombotics Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Anti Thrombotics Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Anti Thrombotics Market Segmentation
4.1. Global Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Blood Clot Prevention
  • Hyperlipidemia Treatment
  • Prophylactic Treatment
  • Thromboembolic Disease Treatment
  • Other Applications
4.2. Global Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Anticoagulant
  • Antiplatelet
  • Thrombolytic Drugs
4.3. Global Anti Thrombotics Market, Segmentation By Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Fondaparinux
  • Heparin
  • Apixaban
  • Debigatran
  • Rivaroxaban
4.4. Global Anti Thrombotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Oral
  • Parenteral Route
4.5. Global Anti Thrombotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Online Retailers
  • General Pharmacies
  • Drug Stores
5. Anti Thrombotics Market Regional And Country Analysis
5.1. Global Anti Thrombotics Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Anti Thrombotics Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Anti Thrombotics Market
6.1. Asia-Pacific Anti Thrombotics Market Overview
6.2. Asia-Pacific Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Anti Thrombotics Market
7.1. China Anti Thrombotics Market Overview
7.2. China Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Anti Thrombotics Market
8.1. India Anti Thrombotics Market Overview
8.2. India Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Anti Thrombotics Market
9.1. Japan Anti Thrombotics Market Overview
9.2. Japan Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Anti Thrombotics Market
10.1. Australia Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Anti Thrombotics Market
11.1. Indonesia Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Anti Thrombotics Market
12.1. South Korea Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Anti Thrombotics Market
13.1. Western Europe Anti Thrombotics Market Overview
13.2. Western Europe Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Anti Thrombotics Market
14.1. UK Anti Thrombotics Market Overview
14.2. UK Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Anti Thrombotics Market
15.1. Germany Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Anti Thrombotics Market
16.4. France Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Anti Thrombotics Market
17.1. Eastern Europe Anti Thrombotics Market Overview
17.2. Eastern Europe Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Anti Thrombotics Market
18.1. Russia Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Anti Thrombotics Market
19.1. North America Anti Thrombotics Market Overview
19.2. North America Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Anti Thrombotics Market
20.1. USA Anti Thrombotics Market Overview
20.2. USA Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Anti Thrombotics Market
21.1. South America Anti Thrombotics Market Overview
21.2. South America Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Anti Thrombotics Market
22.1. Brazil Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Anti Thrombotics Market
23.1. Middle East Anti Thrombotics Market Overview
23.2. Middle East Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Anti Thrombotics Market
24.1. Africa Anti Thrombotics Market Overview
24.2. Africa Anti Thrombotics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Anti Thrombotics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Anti Thrombotics Market Competitive Landscape And Company Profiles
25.1. Anti Thrombotics Market Competitive Landscape
25.2. Anti Thrombotics Market Company Profiles
25.2.1. Bayer AG
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Johnson & Johnson
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Sanofi
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Boehringer Ingelheim Gmbh
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Eli Lilly
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anti Thrombotics Market

27. Anti Thrombotics Market Trends And Strategies

28. Product Pipeline Analysis

29. Anti Thrombotics Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Bristol Myers Squibb
  • Eli Lilly
  • Johnson & Johnson
  • Sanofi
  • MORE
The anti-thrombotic drugs market consists of sales of anti-thrombotic drugs which are used to prevent and treat arterial and venous thrombosis and as well reduce the formation of clots. The anti-thrombotic drugs market is segmented into antiplatelet agents, fibrinolytic drugs, and anticoagulants.

The global anti thrombotics market was valued at about $8.8 billion in 2018 and is expected to decline to $7.73 billion at a CAGR of -3.2% through 2022.

In 2018, North America was the largest region in the anti thrombotics market. The anti thrombotics market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

The rise in the chronic diseases associated with thrombotic diseases is the driving force for the anti-thrombotic drugs market. Thrombotic diseases require long term treatment of antithrombotic drugs. This requirement contribute to the sales of antithrombotic drugs. For example, almost 900,000 people in USA could be affected with DVT (Deep Venous Thrombosis). Also, there is a 33% chance that DVT will come back within 10 years to the same patient.

The increased use of biologics is one of the reasons for the decline in the growth of anti-thrombotic drugs market. Biologics are the medicines derived from living organisms such as humans, animals or microorganisms that may contain protein, sugar, nucleic acids or combination of these substances. Biologics are not chemically synthesized and hence, they don't fall under the category of drugs. As the usage of biologic medicines increases, greater portion of synthetic/chemical drugs business will be taken over affecting the growth of the anti- thrombotic drug market. For example, in the year 2017, Aplagon Oy and Cadila collaborated for the production of anti-thrombotic Biologics. Also, in the year 2018, US FDA approved ATryn, the first ever animal derived biologic anticoagulant product manufactured by GTC Bio therapeutics. Before ATryn, the human blood derived product was the only biologic AT (Anti Thrombin) medicine available in the U.S.

Artificial Intelligence (AI) partnerships are being discussed by almost over 30 major drug manufacturers such as AstraZeneca, Astellas, Bayer, GSK, Janssen and Merck, in order to find and validate new drug targets, monitor adherence, better clinical trial planning and operations, identification of proteins, pharmacovigilance (monitoring adverse events), drug repurposing, and prediction of disease. AI could be very beneficial in disease prediction. For example, Janssen recently announced an agreement with Winterlight Labs to use Winterlight’s voice analysis technology to predict on-set of dementia. Another example by UK’s Francis Crick Institute recently showed that predicting heart disease death by AI was much precise than the prediction by physicians. Thus, improved usage of AI may help drug makers largely, thereby, driving the market strongly.

The FDA approvals of various anti-thrombotic drugs impacts the market positively. FDA approves a few drugs under “Fast Track designation” as a “priority review” when no adequate therapy exists. For example, FDA Approved Bevyxxa, the first and only anticoagulant for hospital and extended duration prophylaxis of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for VTE. Approximately 24 million acutely ill medical patients are hospitalized each year and are at risk of VTE, either while in the hospital or following discharge. The speedy approval by FDA drives the growth of anti-thrombotic drugs market. In May 2019, FDA approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients of one month age and older. Hence, these approvals would as well encourage the drug manufacturers to spend on Research & Development but would also act as a driver.

In the year 2018, Sanofi acquired Bioverativ for $11.6 Billion. The acquisition helped Sanofi to mark its presence in in rare blood disorder and specialty care. Bioverative Inc. is headquartered in Walthan, United States and was established in the year 2016.

Major players in the market are Bayer AG, Johnson & Johnson, Sanofi, Boehringer Ingelheim Gmbh and Eli Lilly.
Note: Product cover images may vary from those shown
5 of 5
  • Bayer AG
  • Johnson & Johnson
  • Sanofi
  • Boehringer Ingelheim Gmbh
  • Eli Lilly
  • The Medicines Co.
  • Genentech
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Bristol Myers Squibb
  • Dr. Reddy's Laboratories
  • AstraZeneca
  • Abbott
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll